Education
About Us
Working with TipRanks
Follow Us
Alain Wilson Insider Profile
4 Followers
Alain Wilson, Chief Financial Officer at Antibe Therapeutics, holds 242.01K shares in Antibe Therapeutics (Ticker: ATBPF).
Alain Wilson Antibe Therapeutics (ATBPF)Chief Financial Officer
Antibe Therapeutics (ATBPF)
Chief Financial Officer
Ranked #100,445 out of 106,131 Corporate Insiders
Profitable Transactions
1 out of 5 Profitable Transactions
Average Return
-61.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Alain Wilson does not currently own shares as a corporate insider.
A breakdown of Alain Wilson's holdings
Insider Roles
Alain Wilson does not currently hold a role as a corporate insider.
Roles that Alain Wilson holds in companies
Most Profitable Insider Trade
Stock:
Antibe Therapeutics
(ATBPF)
(ATBPF)
Rating:Informative Buy
Date:Sep 20, 2018 - Sep 20, 2019
Return:+28.60%
The most profitable trade made by Alain Wilson
Alain Wilson's Trading History
List of latest transactions for each holding click on a transaction to see Alain Wilson's performance on stock
You May Also Like
Alain Wilson insider profile FAQ
What is the percentage of profitable transactions made by Alain Wilson?
The percentage of profitable transactions made by Alain Wilson is 20%.
What is the average return per transaction made by Alain Wilson?
The average return per transaction made by Alain Wilson is -61.50%.
What stocks does Alain Wilson hold?
Alain Wilson holds: ATBPF stocks.
What was Alain Wilson’s latest transaction?
Alain Wilson latest transaction was an Uninformative Sell of ―.
What was Alain Wilson's most profitable transaction?
Alain Wilson’s most profitable transaction was an Informative Buy of ATBPF stock on September 20, 2018. The return on the trade was 28.60%.
What is Alain Wilson's role in Antibe Therapeutics?
Alain Wilson's role in Antibe Therapeutics is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.